Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis

Conclusion: Providing patients who declined warfarin therapy with information about their genetic risk of AF would be cost effective if this genetic risk information resulted in modest increases in adherence.
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Source Type: research